References
- Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjögren syndrome-associated neuropathy. Brain. 2005;128:2518–34.
- Gorson KC, Ropper AH. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications. Muscle Nerve. 2003;28:553–60.
- Hoitsma E, Reulen JP, de Baets M, Drent M, Spaans F, Faber CG. Small fiber neuropathy: a common and important clinical disor-der. J Neurol Sci. 2004;227:119–30.
- Al-Shekhlee A, Chelimsky TC, Preston DC. Review: small-fiber neuropathy. Neurologist. 2002;8:237–53.
- Chai J, Herrmann DN, Stanton M, Barbano RL, Loqiqian EL. Painful small-fiber neuropathy in Sjögren syndrome. Neurology. 2005;65:925–7.
- Vitali C, Bambardieri S, Jonsson R, Moutsopoulos HM, Alex-ander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American—European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
- Goransson LG, Herigstad A, Tjensvoll AB, Harboe E, Mellqren SI, Omdal R. Peripheral neuropathy in primary Sjögren's syn-drome. A population-based study. Arch Neurol. 2006;63:1612–5.
- Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjögren's syndrome. A study of 82 patients. Medicine (Baltimore). 2004; 83:280–91.
- Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuropathy with Sjögren's syndrome. Neurology. 2003;60:503–5.
- Kizawa M, Mori K, Iijima M, Koike H, Hattori N, Sobue G. Intravenous immunoglobulin treatment in painful sensory neu-ropathy without sensory ataxia associated with Sjögren syn-drome. J Neurol Neurosurg Psychiatry. 2006;77:967–9.
- Levy Y, Uziel Y, Zandman GG, Amital H, Sherer Y, Langevitz P, et al. Intravenous immunoglobulins in peripheral neuropathy associated with vasculitis. Ann Rheum Dis. 2003;62:1221–3.
- van Doom PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol. 1990;29:57–64.
- Saoudi A, Hurez V, de Kozak Y, Huhn J, Kaveri SV, Kazatchine MD, et al. Human immunoglobulin preparations for intravenous use prevent experimental autoimmune uveoretinitis. Int Immunol. 1990;5:1559–67.
- Anderson CL. Human IgG Fc receptor. Clin Immunol Immuno-pathol. 1989;53:S63–71.